Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Richard Hyer
Authored Items
Is SLIT Coming Soon to the United States?
Richard Hyer
Web Exclusives
Inpatient Treatment of Asthma Is Costly
Richard Hyer
Web Exclusives
New Performance Markers of Ciclesonide Aqueous Nasal Spray for Seasonal Allergic Rhinitis
Richard Hyer
Web Exclusives
Mometasone Furoate Nasal Spray Provides Sustained Symptom Relief in Allergic Rhinitis
Richard Hyer
Web Exclusives
Significant Advances in the Treatment of Seasonal Allergies
Richard Hyer
Web Exclusives
Novel Approaches to Immunotherapy: Immunomodulation
Richard Hyer
Web Exclusives
Investigational Ciclesonide HFA Safe and Effective for Seasonal Allergic Rhinitis
Richard Hyer
Web Exclusives
Last modified: April 21, 2011